Matthew Claxton, DPM
Podiatrist · Saint Louis, MONPI 1457466989
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,951 of the $4,828 with a category attached, or 61.1%. 18 manufacturers reported payments, led by Arthrex at 32.1% of the total. Reporting peaked in 2023 at $1,754 and has fallen 88.6% since, to $199 in 2025.
Across 122 payments — averaging $39.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Organogenesis Inc.$1K
- Elite Orthopedics, LLC$1K
- Stryker$320
- Convatec Inc.$182
- Avita Medical Americas, LLC$150
- plus $546 from 12 others
What the payments were for
- Speaking & faculty fees$1,00021%
- Travel & lodging$87718%
- Food & beverage$2,95161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 13 | $1,548 |
| Organogenesis Inc. | 70 | $1,075 |
| Elite Orthopedics, LLC | 11 | $1,008 |
| Stryker(2 entities) | 10 | $320 |
| Convatec Inc. | 2 | $182 |
| Avita Medical Americas, LLC | 1 | $150 |
| Arthrosurface Incorporated | 2 | $148 |
| Amgen | 1 | $125 |
| Cardiovascular Systems Inc. | 1 | $49 |
| Paragon 28, Inc. | 2 | $39 |
| Integra Lifesciences Corporation | 2 | $37 |
| Kerecis Limited | 1 | $32 |
| Averitas Pharma Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Treace Medical Concepts, Inc. | 1 | $21 |
| Melinta Therapeutics, LLC | 1 | $17 |
| Nextremity Solutions Inc. | 1 | $17 |
| Zimmer Biomet | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RECELL$150
- Affinity$146
- InnovaMatrix AC$127
- KRYSTEXXA$125
How this compares
$4,828 in reported general payments places this provider in the 75th percentile of 105 podiatrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $6,964 |
| Gentamicin Sulfate | 80 | $3,001 |
| Pregabalin | 76 | $2,316 |
| Gabapentin | 95 | $1,668 |
| Celecoxib | 19 | $1,512 |
| Doxycycline Hyclate | 79 | $808 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 104 | $680 |
| Felodipine ErFelodipine | 17 | $407 |
| Terbinafine Hcl | 24 | $328 |
| Ketoconazole | 19 | $258 |
| Colchicine | 12 | $216 |
| Allopurinol | 40 | $199 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $176 |
| Ammonium Lactate | 22 | $161 |
| Meloxicam | 36 | $111 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Saint Louis
- Kiera Benge-SheaSaint Louis$28K
- Neil ErmitanoSaint Louis$14K
- Daniel NarowitzSaint Louis$12K
- Jay MoradiaSaint Louis$11K
- Tracy ReedSaint Louis$8K
- Michael HoenigSaint Louis$5K
- Caleb WhiteSaint Louis$4K
- Christopher ForsbachSaint Louis$3K
- Stephen SehySaint Louis$1K
- Michael HorwitzSaint Louis$899
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.